Maithili Life Sciences Private Limited
Overview
Pharmaceutical manufacturing site surfaced via EU GMP non-compliance screening (EudraGMDP).
API / Drug Master Files
Maithili Life Sciences Private Limited holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- BILASTINEActive2026-01-30
- CHLORZOXAZONE USPActive2025-10-11
- EZETIMIBE USPActive2025-06-13
- DORZOLAMIDE HYDROCHLORIDE USPActive2025-04-08
FDA compliance signals
2 FDA enforcement records linked to this company.
- eu_noncompliance2025-10-14
EU GMP Statement of Non-Compliance
- eu_noncompliance2025-01-13
EU GMP Statement of Non-Compliance
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.